NOTCH signaling in lung diseases

References

• Andersson ER, Sandberg R, Lendahl U. NOTCH signaling: simplicity in design, versatility in function. Development. 2011;138:3593–3612.
   Google Scholar
• Artavanis-Tsakonas S, Rand MD, Lake RJ. NOTCH signaling: cell fate control and signal integration in development. Science. 1999;284:770–776.
   Google Scholar
• Yoon K, Gaiano N. NOTCH signaling in the mammalian central nervous system: insights from mouse mutants. Nat Neurosci. 2005;8:709–715.
   Google Scholar
• Niessen K, Karsan A. NOTCH signaling in the developing cardiovascular system. Am J Physiol Cell Physiol. 2007;293:C1–C11.
   Google Scholar
• Afelik S, Jensen J. NOTCH signaling in the pancreas: patterning and cell fate specification. Wiley Interdiscip Rev Dev Biol. 2013;2:531–544.
   Google Scholar
• Xu K, Moghal N, Egan SE. NOTCH signaling in lung development and disease. Adv Exp Med Biol. 2012;727:89–98.
   Google Scholar
• Gridley T. NOTCH signaling and inherited disease syndromes. Hum Mol Genet. 2003;12(Spec No. 1):R9–R13.
   Google Scholar
• Aster JC. In brief: NOTCH signalling in health and disease. J Pathol. 2014;232:1–3.
   Google Scholar
• Kong Y, Glickman J, Subramaniam M, Shahsafaei A, Allamneni KP, Aster JC, et al. Functional diversity of NOTCH family genes in fetal lung development. Am J Physiol Lung Cell Mol Physiol. 2004;286:L1075–L1083.
   Google Scholar
• Tsao PN, Chen F, Izvolsky KI, Walker J, Kukuruzinska MA, Lu J, et al. Gamma-secretase activation of NOTCH signaling regulates the balance of proximal and distal fates in progenitor cells of the developing lung. J Biol Chem. 2008;283:29532–29544.
   Google Scholar
• Dang TP, Eichenberger S, Gonzalez A, Olson S, Carbone DP. Constitutive activation of NOTCH3 inhibits terminal epithelial differentiation in lungs of transgenic mice. Oncogene. 2003;22:1988–1997.
   Google Scholar
• Guseh JS, Bores SA, Stanger BZ, Zhou Q, Anderson WJ, Melton DA, et al. NOTCH signaling promotes airway mucous metaplasia and inhibits alveolar development. Development. 2009;136:1751–1759.
   Google Scholar
• Gridley T. NOTCH signaling in vascular development and physiology. Development. 2007;134:2709–2718.
   Google Scholar
• Taichman DB, Loomes KM, Schachtner SK, Guttentag S, Vu C, Williams P, et al. NOTCH1 and Jagged1 expression by the developing pulmonary vasculature. Dev Dyn. 2002;225:166–175.
   Google Scholar
• Miniati D, Jelin EB, Ng J, Wu J, Carlson TR, Wu X, et al. Constitutively active endothelial Notch4 causes lung arteriovenous shunts in mice. Am J Physiol Lung Cell Mol Physiol. 2010;298:L169–L177.
   Google Scholar
• Radtke F, MacDonald HR, Tacchini-Cottier F. Regulation of innate and adaptive immunity by Notch. Nat Rev Immunol. 2013;13:427–437.
   Google Scholar
• Minter LM, Turley DM, Das P, Shin HM, Joshi I, Lawlor RG, et al. Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21. Nat Immunol. 2005;6:680–688.
   Google Scholar
• Amsen D, Antov A, Jankovic D, Sher A, Radtke F, Souabni A, et al. Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch. Immunity. 2007;27:89–99.
   Google Scholar
• Yu S, Liu C, Li L, Tian T, Wang M, Hu Y, et al. Inactivation of Notch signaling reverses the Th17/Treg imbalance in cells from patients with immune thrombocytopenia. Lab Invest. 2015;95:157–167.
   Google Scholar
• Samon JB, Champhekar A, Minter LM, Telfer JC, Miele L, Fauq A, et al. Notch1 and TGFβ1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells. Blood. 2008;112:1813–1821.
   Google Scholar
• Dongre A, Surampudi L, Lawlor RG, Fauq AH, Miele L, Golde TE, et al. Non-canonical Notch signaling drives activation and differentiation of peripheral CD4+ T cells. Front Immunol. 2014;5:54.
   Google Scholar
• Olin JT, Wechsler ME. Asthma: pathogenesis and novel drugs for treatment. Brit Med J. 2014;349:g5517.
   Google Scholar
• Kang JH, Lee DH, Lee JS, Kim HJ, Shin JW, Lee YH, et al. Eosinophilic differentiation is promoted by blockage of Notch signaling with a gamma-secretase inhibitor. Eur J Immunol. 2005;35:2982–2990.
   Google Scholar
• Zhang W, Nie Y, Chong L, Cai X, Zhang H, Lin B, et al. PI3K and NOTCH signal pathways coordinately regulate the activation and proliferation of T lymphocytes in asthma. Life Sci. 2013;92:890–895.
   Google Scholar
• Mazzarella G, Bianco A, Catena E, De Palma R, Abbate GF. Th1/Th2 lymphocyte polarization in asthma. Allergy. 2000;61(55 Suppl):6–9.
   Google Scholar
• Amsen D, Blander JM, Lee GR, Tanigaki K, Honjo T, Flavell RA. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell. 2004;117:515–526.
   Google Scholar
• Liotta F, Frosali F, Querci V, Mantei A, Fili L, Maggi L, et al. Human immature myeloid dendritic cells trigger a TH2-polarizing program via Jagged-1/Notch interaction. J Allergy Clin Immunol. 2008;121:1000–1005 e1008.
   Google Scholar
• Gu W, Xu W, Ding T, Guo X. Fringe controls naive CD4(+)T cells differentiation through modulating notch signaling in asthmatic rat models. PLoS ONE. 2012;7:e47288.
   Google Scholar
• Kang JH, Kim BS, Uhm TG, Lee SH, Lee GR, Park CS, et al. Gamma-secretase inhibitor reduces allergic pulmonary inflammation by modulating Th1 and Th2 responses. Am J Respir Crit Care Med. 2009;179:875–882.
   Google Scholar
• Okamoto M, Matsuda H, Joetham A, Lucas JJ, Domenico J, Yasutomo K, et al. Jagged1 on dendritic cells and Notch on CD4+ T cells initiate lung allergic responsiveness by inducing IL-4 production. J Immunol. 2009;183:2995–3003.
   Google Scholar
• Guo XJ, Zhou M, Ren LP, Yang M, Huang SG, Xu WG. Small interfering RNA-mediated knockdown of Notch1 in lung. Chin Med J (Engl). 2009;122:2647–2651.
   Google Scholar
• Zhou M, Cui ZL, Guo XJ, Ren LP, Yang M, Fan ZW, et al. Blockade of Notch signalling by gamma-secretase inhibitor in lung T cells of asthmatic mice affects T cell differentiation and pulmonary inflammation. Inflammation. 2015.
   Google Scholar
• Chong L, Zhang W, Nie Y, Yu G, Liu L, Lin L, et al. Protective effect of curcumin on acute airway inflammation of allergic asthma in mice through Notch1-GATA3 signaling pathway. Inflammation. 2014;37:1476–1485.
   Google Scholar
• Brugnolo F, Sampognaro S, Liotta F, Cosmi L, Annunziato F, Manuelli C, et al. The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-gamma-producing cells. J Allergy Clin Immunol. 2003;111:380–388.
   Google Scholar
• Moisan J, Camateros P, Thuraisingam T, Marion D, Koohsari H, Martin P, et al. TLR7 ligand prevents allergen-induced airway hyperresponsiveness and eosinophilia in allergic asthma by a MYD88-dependent and MK2-independent pathway. Am J Physiol Lung Cell Mol Physiol. 2006;290:L987–995.
   Google Scholar
• Edwards S, Jones C, Leishman AJ, Young BW, Matsui H, Tomizawa H, et al. TLR7 stimulation of APCs results in inhibition of IL-5 through type I IFN and Notch signaling pathways in human peripheral blood mononuclear cells. J Immunol. 2013;190:2585–2592.
   Google Scholar
• Mauad T, Dolhnikoff M. Pathologic similarities and differences between asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2008;14:31–38.
   Google Scholar
• Tilley AE, Harvey BG, Heguy A, Hackett NR, Wang R, O'Connor TP, et al. Downregulation of the NOTCH pathway in human airway epithelium in association with smoking and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;179:457–466.
   Google Scholar
• Ou-Yang HF, Wu CG, Qu SY, Li ZK. Notch signaling downregulates MUC5AC expression in airway epithelial cells through Hes1-dependent mechanisms. Respiration. 2013;86:341–346.
   Google Scholar
• Boucherat O, Chakir J, Jeannotte L. The loss of Hoxa5 function promotes Notch-dependent goblet cell metaplasia in lung airways. Biol Open. 2012;1:677–691.
   Google Scholar
• Aoshiba K, Nagai A. Differences in airway remodeling between asthma and chronic obstructive pulmonary disease. Clin Rev Allergy Immunol. 2004;27:35–43.
   Google Scholar
• Harkness LM, Ashton AW, Burgess JK. Asthma is not only an airway disease, but also a vascular disease. Pharmacol Ther. 2015;148C:17–33.
   Google Scholar
• Kume T. Ligand-dependent Notch signaling in vascular formation. Adv Exp Med Biol. 2012;727:210–222.
   Google Scholar
• Huang MT, Dai YS, Chou YB, Juan YH, Wang CC, Chiang BL. Regulatory T cells negatively regulate neovasculature of airway remodeling via DLL4-Notch signaling. J Immunol. 2009;183:4745–4754.
   Google Scholar
• Churg A, Tai H, Coulthard T, Wang R, Wright JL. Cigarette smoke drives small airway remodeling by induction of growth factors in the airway wall. Am J Respir Crit Care Med. 2006;174:1327–1334.
   Google Scholar
• Aoyagi-Ikeda K, Maeno T, Matsui H, Ueno M, Hara K, Aoki Y, et al. Notch induces myofibroblast differentiation of alveolar epithelial cells via transforming growth factor-β-Smad3 pathway. Am J Respir Cell Mol Biol. 2011;45:136–144.
   Google Scholar
• Vaughan AE, Brumwell AN, Xi Y, Gotts JE, Brownfield DG, Treutlein B, et al. Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury. Nature. 2015;517:621–625.
   Google Scholar
• Cao Z, Lis R, Ginsberg M, Chavez D, Shido K, Rabbany SY, et al. Targeting of the pulmonary capillary vascular niche promotes lung alveolar repair and ameliorates fibrosis. Nat Med. 2016;22:154–162.
   Google Scholar
• Hu B, Wu Z, Bai D, Liu T, Ullenbruch MR, Phan SH. Mesenchymal deficiency of Notch1 attenuates bleomycin-induced pulmonary fibrosis. Am J Pathol. 2015;185:3066–3075.
   Google Scholar
• Fouillade C, Monet-Lepretre M, Baron-Menguy C, Joutel A. Notch signalling in smooth muscle cells during development and disease. Cardiovasc Res. 2012;95:138–146.
   Google Scholar
• Roca C, Adams RH. Regulation of vascular morphogenesis by Notch signaling. Genes Dev. 2007;21:2511–2524.
   Google Scholar
• Phng LK, Gerhardt H. Angiogenesis: a team effort coordinated by notch. Dev Cell. 2009;16:196–208.
   Google Scholar
• Morimoto M, Liu Z, Cheng HT, Winters N, Bader D, Kopan R. Canonical Notch signaling in the developing lung is required for determination of arterial smooth muscle cells and selection of Clara versus ciliated cell fate. J Cell Sci. 2010;123:213–224.
   Google Scholar
• Havrda MC, Johnson MJ, O'Neill CF, Liaw L. A novel mechanism of transcriptional repression of p27kip1 through Notch/HRT2 signaling in vascular smooth muscle cells. Thromb Haemost. 2006;96:361–370.
   Google Scholar
• Thistlethwaite PA, Li X, Zhang X. Notch signaling in pulmonary hypertension. Adv Exp Med Biol. 2010;661:279–298.
   Google Scholar
• Chida A, Shintani M, Matsushita Y, Sato H, Eitoku T, Nakayama T, et al. Mutations of NOTCH3 in childhood pulmonary arterial hypertension. Mol Genet Genomic Med. 2014;2:229–239.
   Google Scholar
• Li X, Zhang X, Leathers R, Makino A, Huang C, Parsa P, et al. Notch3 signaling promotes the development of pulmonary arterial hypertension. Nat Med. 2009;15:1289–1297.
   Google Scholar
• Yu YR, Mao L, Piantadosi CA, Gunn MD. CCR2 deficiency, dysregulation of Notch signaling, and spontaneous pulmonary arterial hypertension. Am J Respir Cell Mol Biol. 2013;48:647–654.
   Google Scholar
• Qiao L, Xie L, Shi K, Zhou T, Hua Y, Liu H. Notch signaling change in pulmonary vascular remodeling in rats with pulmonary hypertension and its implication for therapeutic intervention. PLoS ONE. 2012;7:e51514.
   Google Scholar
• Antoniu SA. Targeting PDGF pathway in pulmonary arterial hypertension. Expert Opin Ther Targets. 2012;16:1055–1063.
   Google Scholar
• Maron BA, Leopold JA. The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series). Pulm Circ. 2014;4:200–210.
   Google Scholar
• Qiao LN, Wang XM, Liu ZQ, Wang XQ, Zhou TF, Hua YM, et al. The influence of inhibiting notch signal on pulmonary vascular remodeling induced by PDGF. Sichuan Da Xue Xue Bao Yi Xue Ban. 2011;42:766–770.
   Google Scholar
• Qiao LN, Xu HB, Shi K, Zhou TF, Hua YM, Liu HM. Effect of inhibition of Notch signal on pulmonary vascular remodeling induced by angiotensin. Zhongguo Dang Dai Er Ke Za Zhi. 2011;13:503–508.
   Google Scholar
• Masuya M, Katayama N, Hoshino N, Nishikawa H, Sakano S, Araki H, et al. The soluble Notch ligand, Jagged-1 inhibits proliferation of CD34+ macrophage progenitors. Int J Hematol. 2002;75:269–276.
   Google Scholar
• Xiao Y, Gong D, Wang W. Soluble JAGGED1 inhibits pulmonary hypertension by attenuating notch signaling. Arterioscler Thromb Vasc Biol. 2013;33:2733–2739.
   Google Scholar
• Yang XR, Lin MJ, Sham JS. Physiological functions of transient receptor potential channels in pulmonary arterial smooth muscle cells. Adv Exp Med Biol. 2010;661:109–122.
   Google Scholar
• Yamamura H, Yamamura A, Ko EA, Pohl NM, Smith KA, Zeifman A, et al. Activation of Notch signaling by short-term treatment with Jagged-1 enhances store-operated Ca(2+) entry in human pulmonary arterial smooth muscle cells. Am J Physiol Cell Physiol. 2014;306:C871–C878.
   Google Scholar
• Smith KA, Voiriot G, Tang H, Fraidenburg DR, Song S, Yamamura H, et al. Notch activation of Ca signaling mediates hypoxic pulmonary vasoconstriction and pulmonary hypertension. Am J Respir Cell Mol Biol. 2015.
   Google Scholar
• Dang TP, Gazdar AF, Virmani AK, Sepetavec T, Hande KR, Minna JD, et al. Chromosome 19 translocation, overexpression of Notch3, and human lung cancer. J Natl Cancer Inst. 2000;92:1355–1357.
   Google Scholar
• Jiang X, Zhou JH, Deng ZH, Qu XH, Jiang HY, Liu Y. Expression and significance of Notch1, Jagged1 and VEGF in human non-small cell lung cancer. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2007;32:1031–1036.
   Google Scholar
• Cao H, Hu Y, Wang P, Zhou J, Deng Z, Wen J. Down-regulation of Notch receptor signaling pathway induces caspase-dependent and caspase-independent apoptosis in lung squamous cell carcinoma cells. APMIS. 2012;120:441–450.
   Google Scholar
• Westhoff B, Colaluca IN, D'Ario G, Donzelli M, Tosoni D, Volorio S, et al. Alterations of the Notch pathway in lung cancer. Proc Natl Acad Sci USA. 2009;106:22293–22298.
   Google Scholar
• Donnem T, Andersen S, Al-Shibli K, Al-Saad S, Busund LT, Bremnes RM. Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch-1 and vascular endothelial growth factor-A predicts poor survival. Cancer. 2010;116:5676–5685.
   Google Scholar
• Hassan KA, Wang L, Korkaya H, Chen G, Maillard I, Beer DG, et al. Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma. Clin Cancer Res. 2013;19:1972–1980.
   Google Scholar
• Theys J, Yahyanejad S, Habets R, Span P, Dubois L, Paesmans K, et al. High NOTCH activity induces radiation resistance in non small cell lung cancer. Radiother Oncol. 2013;108:440–445.
   Google Scholar
• Ye YZ, Zhang ZH, Fan XY, Xu XL, Chen ML, Chang BW, et al. Notch3 overexpression associates with poor prognosis in human non-small-cell lung cancer. Med Oncol. 2013;30:595.
   Google Scholar
• Zhou M, Jin WY, Fan ZW, Han RC. Analysis of the expression of the Notch3 receptor protein in adult lung cancer. Oncol Lett. 2013;5:499–504.
   Google Scholar
• Zhou L, Wu SW, Yu L, Gong XM, Song WQ, Cheng ZN. Expression of CD133 and Notch1 in non-small cell lung cancer and the clinicopathological significance. Nan Fang Yi Ke Da Xue Xue Bao. 2015;35:196–201.
   Google Scholar
• Xu Y, Wang Y, Liu H, Kang X, Li W, Wei Q. Genetic variants of genes in the Notch signaling pathway predict overall survival of non-small cell lung cancer patients in the PLCO study. Oncotarget. 2016.
   Google Scholar
• Shi C, Qian J, Ma M, Zhang Y, Han B. Notch 3 protein, not its gene polymorphism, is associated with the chemotherapy response and prognosis of advanced NSCLC patients. Cell Physiol Biochem. 2014;34:743–752.
   Google Scholar
• Huang J, Song H, Liu B, Yu B, Wang R, Chen L. Expression of Notch-1 and its clinical significance in different histological subtypes of human lung adenocarcinoma. J Exp Clin Cancer Res. 2013;32:84.
   Google Scholar
• Yuan X, Wu H, Xu H, Han N, Chu Q, Yu S, et al. Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis. Sci Rep. 2015;5:10338.
   Google Scholar
• Hu XB, Feng F, Wang YC, Wang L, He F, Dou GR, et al. Blockade of Notch signaling in tumor-bearing mice may lead to tumor regression, progression, or metastasis, depending on tumor cell types. Neoplasia. 2009;11:32–38.
   Google Scholar
• Allen TD, Rodriguez EM, Jones KD, Bishop JM. Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma. Cancer Res. 2011;71:6010–6018.
   Google Scholar
• Baumgart A, Seidl S, Vlachou P, Michel L, Mitova N, Schatz N, et al. ADAM17 regulates epidermal growth factor receptor expression through the activation of Notch1 in non-small cell lung cancer. Cancer Res. 2010;70:5368–5378.
   Google Scholar
• Eliasz S, Liang S, Chen Y, De Marco MA, Machek O, Skucha S, et al. Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway. Oncogene. 2010;29:2488–2498.
   Google Scholar
• Konishi J, Yi F, Chen X, Vo H, Carbone DP, Dang TP. Notch3 cooperates with the EGFR pathway to modulate apoptosis through the induction of bim. Oncogene. 2010;29:589–596.
   Google Scholar
• Haruki N, Kawaguchi KS, Eichenberger S, Massion PP, Olson S, Gonzalez A, et al. Dominant-negative Notch3 receptor inhibits mitogen-activated protein kinase pathway and the growth of human lung cancers. Cancer Res. 2005;65:3555–3561.
   Google Scholar
• Konishi J, Kawaguchi KS, Vo H, Haruki N, Gonzalez A, Carbone DP, et al. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers. Cancer Res. 2007;67:8051–8057.
   Google Scholar
• Osanyingbemi-Obidi J, Dobromilskaya I, Illei PB, Hann CL, Rudin CM. Notch signaling contributes to lung cancer clonogenic capacity in vitro but may be circumvented in tumorigenesis in vivo. Mol Cancer Res. 2011;9:1746–1754.
   Google Scholar
• Lin L, Mernaugh R, Yi F, Blum D, Carbone DP, Dang TP. Targeting specific regions of the Notch3 ligand-binding domain induces apoptosis and inhibits tumor growth in lung cancer. Cancer Res. 2010;70:632–638.
   Google Scholar
• Chen Y, De Marco MA, Graziani I, Gazdar AF, Strack PR, Miele L, et al. Oxygen concentration determines the biological effects of NOTCH-1 signaling in adenocarcinoma of the lung. Cancer Res. 2007;67:7954–7959.
   Google Scholar
• Chen Y, Li D, Liu H, Xu H, Zheng H, Qian F, et al. Notch-1 signaling facilitates survivin expression in human non-small cell lung cancer cells. Cancer Biol Ther. 2011;11:14–21.
   Google Scholar
• Sullivan JP, Spinola M, Dodge M, Raso MG, Behrens C, Gao B, et al. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res. 2010;70:9937–9948.
   Google Scholar
• Zheng Y, de la Cruz CC, Sayles LC, Alleyne-Chin C, Vaka D, Knaak TD, et al. A rare population of CD24(+)ITGB4(+)Notch(hi) cells drives tumor propagation in NSCLC and requires Notch3 for self-renewal. Cancer Cell. 2013;24:59–74.
   Google Scholar
• Arasada RR, Amann JM, Rahman MA, Huppert SS, Carbone DP. EGFR blockade enriches for lung cancer stem-like cells through Notch3-dependent signaling. Cancer Res. 2014;74:5572–5584.
   Google Scholar
• Liu YP, Yang CJ, Huang MS, Yeh CT, Wu AT, Lee YC, et al. Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling. Cancer Res. 2013;73:406–416.
   Google Scholar
• Liu J, Mao Z, Huang J, Xie S, Liu T, Mao Z. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy. Biochem Biophys Res Commun. 2014;444:670–675.
   Google Scholar
• Liu L, Chen X, Wang Y, Qu Z, Lu Q, Zhao J, et al. Notch3 is important for TGF-beta-induced epithelial-mesenchymal transition in non-small cell lung cancer bone metastasis by regulating ZEB-1. Cancer Gene Ther. 2014;21:364–372.
   Google Scholar
• Xie M, Zhang L, He CS, Xu F, Liu JL, Hu ZH, et al. Activation of Notch-1 enhances epithelial-mesenchymal transition in gefitinib-acquired resistant lung cancer cells. J Cell Biochem. 2012;113:1501–1513.
   Google Scholar
• Xie M, He CS, Wei SH, Zhang L. Notch-1 contributes to epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance in non-small cell lung cancer in vitro and in vivo. Eur J Cancer. 2013;49:3559–3572.
   Google Scholar
• Mizugaki H, Sakakibara-Konishi J, Ikezawa Y, Kikuchi J, Kikuchi E, Oizumi S, et al. Gamma-secretase inhibitor enhances anti-tumour effect of radiation in Notch-expressing lung cancer. Br J Cancer. 2012;106:1953–1959.
   Google Scholar
• Kang J, Kim E, Kim W, Seong KM, Youn H, Kim JW, et al. Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (EMT) by miR-34a-mediated suppression of Notch-1 expression in non-small cell lung cancer cell lines. J Biol Chem. 2013;288:27343–27357.
   Google Scholar
• Baumgart A, Mazur PK, Anton M, Rudelius M, Schwamborn K, Feuchtinger A, et al. Opposing role of Notch1 and Notch2 in a Kras(G12D)-driven murine non-small cell lung cancer model. Oncogene. 2015;34:578–588.
   Google Scholar
• Li C, Zhang Y, Lu Y, Cui Z, Yu M, Zhang S, et al. Evidence of the cross talk between Wnt and Notch signaling pathways in non-small-cell lung cancer (NSCLC): Notch3-siRNA weakens the effect of LiCl on the cell cycle of NSCLC cell lines. J Cancer Res Clin Oncol. 2011;137:771–778.
   Google Scholar
• Li C, Zhang S, Lu Y, Zhang Y, Wang E, Cui Z. The roles of Notch3 on the cell proliferation and apoptosis induced by CHIR99021 in NSCLC cell lines: a functional link between Wnt and Notch signaling pathways. PLoS ONE. 2013;8:e84659.
   Google Scholar
• Ohnuki H, Jiang K, Wang D, Salvucci O, Kwak H, Sanchez-Martin D, et al. Tumor-infiltrating myeloid cells activate Dll4/Notch/TGF-beta signaling to drive malignant progression. Cancer Res. 2014;74:2038–2049.
   Google Scholar
• Li C, Song G, Zhang S, Wang E, Cui Z. Wnt3a increases the metastatic potential of non-small cell lung cancer cells in vitro in part via its upregulation of Notch3. Oncol Rep. 2015;33:1207–1214.
   Google Scholar
• Ji X, Wang Z, Geamanu A, Sarkar FH, Gupta SV. Inhibition of cell growth and induction of apoptosis in non-small cell lung cancer cells by delta-tocotrienol is associated with notch-1 down-regulation. J Cell Biochem. 2011;112:2773–2783.
   Google Scholar
• Guo J, He L, Yuan P, Wang P, Lu Y, Tong F, et al. ADAM10 over-expression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway. Oncol Rep. 2012;28:1709–1718.
   Google Scholar
• Ji X, Wang Z, Sarkar FH, Gupta SV. Delta-tocotrienol augments cisplatin-induced suppression of non-small cell lung cancer cells via inhibition of the Notch-1 pathway. Anticancer Res. 2012;32:2647–2655.
   Google Scholar
• Ji X, Wang Z, Geamanu A, Goja A, Sarkar FH, Gupta SV. Delta-tocotrienol suppresses Notch-1 pathway by upregulating miR-34a in nonsmall cell lung cancer cells. Int J Cancer. 2012;131:2668–2677.
   Google Scholar
• Xie M, Liu M, He CS. SIRT1 regulates endothelial Notch signaling in lung cancer. PLoS ONE. 2012;7:e45331.
   Google Scholar
• Yi F, Amarasinghe B, Dang TP. Manic fringe inhibits tumor growth by suppressing Notch3 degradation in lung cancer. Am J Cancer Res. 2013;3:490–499.
   Google Scholar
• Zhang S, Long H, Yang YL, Wang Y, Hsieh D, Li W, et al. Inhibition of CK2alpha down-regulates Notch1 signalling in lung cancer cells. J Cell Mol Med. 2013;17:854–862.
   Google Scholar
• Zhou H, Luo Y, Chen JH, Hu J, Luo YZ, Wang W, et al. Knockdown of TRB3 induces apoptosis in human lung adenocarcinoma cells through regulation of Notch 1 expression. Mol Med Rep. 2013;8:47–52.
   Google Scholar
• Capaccione KM, Hong X, Morgan KM, Liu W, Bishop JM, Liu L, et al. Sox9 mediates Notch1-induced mesenchymal features in lung adenocarcinoma. Oncotarget. 2014;5:3636–3650.
   Google Scholar
• Li L, Tan J, Zhang Y, Han N, Di X, Xiao T, et al. DLK1 promotes lung cancer cell invasion through upregulation of MMP9 expression depending on Notch signaling. PLoS ONE. 2014;9:e91509.
   Google Scholar
• Tang Y, Hu C, Yang H, Cao L, Li Y, Deng P, et al. Rnd3 regulates lung cancer cell proliferation through notch signaling. PLoS ONE. 2014;9:e111897.
   Google Scholar
• George J, Lim JS, Jang SJ, Cun Y, Ozretic L, Kong G, et al. Comprehensive genomic profiles of small cell lung cancer. Nature. 2015;524:47–53.
   Google Scholar
• Meder L, Konig K, Ozretic L, Schultheis AM, Ueckeroth F, Ade CP, et al. NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas. Int J Cancer. 2016;138:927–938.
   Google Scholar
• Ito T, Kudoh S, Ichimura T, Fujino K, Hassan WA, Udaka N. Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1. Human Cell. 2016.
   Google Scholar
• Sriuranpong V, Borges MW, Ravi RK, Arnold DR, Nelkin BD, Baylin SB, et al. Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res. 2001;61:3200–3205.
   Google Scholar
• Hassan WA, Yoshida R, Kudoh S, Hasegawa K, Niimori-Kita K, Ito T. Notch1 controls cell invasion and metastasis in small cell lung carcinoma cell lines. Lung Cancer. 2014;86:304–310.
   Google Scholar
• Wael H, Yoshida R, Kudoh S, Hasegawa K, Niimori-Kita K, Ito T. Notch1 signaling controls cell proliferation, apoptosis and differentiation in lung carcinoma. Lung Cancer. 2014;85:131–140.
   Google Scholar
• Hassan WA, Yoshida R, Kudoh S, Kameyama H, Hasegawa K, Niimori-Kita K, et al. Notch1 controls cell chemoresistance in small cell lung carcinoma cells. Thorac Cancer. 2016;7:123–128.
   Google Scholar
• Crabtree JS, Singleton CS, Miele L. Notch signaling in neuroendocrine tumors. Front Oncol. 2016;6:94.
   Google Scholar
• Ding XY, Ding J, Wu K, Wen W, Liu C, Yan HX, et al. Cross-talk between endothelial cells and tumor via delta-like ligand 4/Notch/PTEN signaling inhibits lung cancer growth. Oncogene. 2012;31:2899–2906.
   Google Scholar
• Kuramoto T, Goto H, Mitsuhashi A, Tabata S, Ogawa H, Uehara H, et al. Dll4-Fc, an inhibitor of Dll4-notch signaling, suppresses liver metastasis of small cell lung cancer cells through the downregulation of the NF-kappaB activity. Mol Cancer Ther. 2012;11:2578–2587.
   Google Scholar
• Kim A, Kim EY, Cho EN, Kim HJ, Kim SK, Chang J, et al. Notch1 destabilizes the adherens junction complex through upregulation of the Snail family of E-cadherin repressors in non-small cell lung cancer. Oncol Rep. 2013;30:1423–1429.
   Google Scholar
• Nguyen D, Rubinstein L, Takebe N, Miele L, Tomaszewski JE, Ivy P, et al. Notch1 phenotype and clinical stage progression in non-small cell lung cancer. J Hematol Oncol. 2015;8:9.
   Google Scholar
• Takebe N, Nguyen D, Yang SX. Targeting notch signaling pathway in cancer: clinical development advances and challenges. Pharmacol Ther. 2014;141:140–149.
   Google Scholar